The biotechnology research and experimental development production value in Belgium saw significant fluctuations from 2013 to 2023. The year-on-year variation showed considerable changes, particularly in 2014 with a 329.52% increase, followed by a sharp decline in 2015 with a -73.66% decrease. Subsequent years saw varied growth with notable increases of 67.12% in 2018 and 43.97% in 2021, punctuated by declines in 2019 and 2020.
The production value stood at 1680.0 million Euros in 2023. Over the last two years, growth rates stabilized with a 9.59% increase in 2022 and a 7.85% rise in 2023. The Compound Annual Growth Rate (CAGR) from 2019 to 2023 was 0.95%, reflecting a period of modest growth.
Looking ahead, forecasted data indicate steady growth, with the production value expected to reach 2090.0 million Euros by 2028. The forecasted 5-year CAGR is 3.52%, translating to an overall growth rate of 18.87% from 2024 to 2028.
Future Trends to Watch For:
- Continued investment and innovation in biotechnology research and development.
- Potential fluctuations due to changes in economic conditions, regulatory environments, and technological advancements.
- Increased focus on personalized medicine and biopharmaceuticals as significant contributors to growth.
- Emerging markets and global collaborations expanding the reach and impact of Belgian biotechnology.
